158 related articles for article (PubMed ID: 28668866)
1. Histology-based Combination Induction Chemotherapy for Elderly Patients with Clinical Stage III Non-small Cell Lung Cancer.
Banna GL; Parra HJS; Castaing M; Dieci MV; Anile G; Nicolosi M; Strano S; Marletta F; Guarneri V; Conte P; Lal R
Anticancer Res; 2017 Jul; 37(7):3723-3728. PubMed ID: 28668866
[TBL] [Abstract][Full Text] [Related]
2. Phase II multicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage IIIA and IIIB non-small cell lung cancer.
Hirsh V; Soulieres D; Duclos M; Faria S; Del Vecchio P; Ofiara L; Ayoub JP; Charpentier D; Gruber J; Portelance L; Souhami L
J Thorac Oncol; 2007 Oct; 2(10):927-32. PubMed ID: 17909355
[TBL] [Abstract][Full Text] [Related]
3. Final overall results of a study with a novel triplet induction chemotherapy regimen (PACCAGE) followed by consolidation radiotherapy in locally advanced inoperable non-small cell lung cancer (NSCLC).
Schallier D; Bral S; Ilsen B; Neyns B; Fontaine C; Decoster L; De Mey J; Meysman M; De Grève J
J Thorac Oncol; 2009 Jun; 4(6):728-35. PubMed ID: 19404217
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non small-cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901.
Garrido P; González-Larriba JL; Insa A; Provencio M; Torres A; Isla D; Sanchez JM; Cardenal F; Domine M; Barcelo JR; Tarrazona V; Varela A; Aguilo R; Astudillo J; Muguruza I; Artal A; Hernando-Trancho F; Massuti B; Sanchez-Ronco M; Rosell R
J Clin Oncol; 2007 Oct; 25(30):4736-42. PubMed ID: 17947721
[TBL] [Abstract][Full Text] [Related]
5. A retrospective study: platinum-based induction chemotherapy combined with gemcitabine or paclitaxel for stage IIB-IIIA central non-small-cell lung cancer.
Lv C; Ma Y; Wu N; Yan S; Zheng Q; Sun Y; Li S; Fang J; Yang Y
World J Surg Oncol; 2013 Mar; 11():76. PubMed ID: 23517534
[TBL] [Abstract][Full Text] [Related]
6. A novel triplet regimen with paclitaxel, carboplatin and gemcitabine (PACCAGE) as induction chemotherapy for locally advanced unresectable non small cell lung cancer (NSCLC).
Schallier D; Neyns B; Fontaine C; Steene JV; De Mey J; Meysman M; De Grève J
Lung Cancer; 2007 May; 56(2):247-54. PubMed ID: 17337086
[TBL] [Abstract][Full Text] [Related]
7. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer.
Argiris A; Liptay M; LaCombe M; Marymont M; Kies MS; Sundaresan S; Masters G
Lung Cancer; 2004 Aug; 45(2):243-53. PubMed ID: 15246197
[TBL] [Abstract][Full Text] [Related]
8. Bayesian network meta-comparison of maintenance treatments for stage IIIb/IV non-small-cell lung cancer (NSCLC) patients with good performance status not progressing after first-line induction chemotherapy: results by performance status, EGFR mutation, histology and response to previous induction.
Tan PS; Lopes G; Acharyya S; Bilger M; Haaland B
Eur J Cancer; 2015 Nov; 51(16):2330-44. PubMed ID: 26364517
[TBL] [Abstract][Full Text] [Related]
9. A three-drug induction chemotherapy with gemcitabine, carboplatin, and paclitaxel for stage III non-small cell lung cancer.
Banna GL; Lipari H; Nicolosi M; Basile A; Fraggetta F; Vaglica M; Marletta F; Urso OE; Ippolito M; Terminella A; Saita S
Med Oncol; 2013 Jun; 30(2):533. PubMed ID: 23512427
[TBL] [Abstract][Full Text] [Related]
10. Implications of delayed initiation of radiotherapy: accelerated repopulation after induction chemotherapy for stage III non-small cell lung cancer.
Chen CP; Weinberg VK; Jahan TM; Jablons DM; Yom SS
J Thorac Oncol; 2011 Nov; 6(11):1857-64. PubMed ID: 21964528
[TBL] [Abstract][Full Text] [Related]
11. Multimodality treatment of stage III non-small cell lung cancer: analysis of a phase II trial using preoperative cisplatin and gemcitabine with concurrent radiotherapy.
D'Angelillo RM; Trodella L; Ciresa M; Cellini F; Fiore M; Greco C; Pompeo E; Mineo TC; Paleari L; Granone P; Ramella S; Cesario A
J Thorac Oncol; 2009 Dec; 4(12):1517-23. PubMed ID: 19875976
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of induction high-dose chemotherapy followed by surgical resection and radiation therapy for patients with marginally resectable non-small cell carcinoma of the lung.
Schilder RJ; Goldberg M; Millenson MM; Movsas B; Rogatko A; Rogers B; Langer CJ
Lung Cancer; 2000 Jan; 27(1):37-45. PubMed ID: 10672782
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of pemetrexed and cisplatin, with chest radiotherapy followed by docetaxel in patients with stage III non-small cell lung cancer.
Gadgeel SM; Ruckdeschel JC; Patel BB; Wozniak A; Konski A; Valdivieso M; Hackstock D; Chen W; Belzer K; Burger AM; Marquette L; Turrisi A
J Thorac Oncol; 2011 May; 6(5):927-33. PubMed ID: 21415776
[TBL] [Abstract][Full Text] [Related]
14. A 3-week schedule of gemcitabine plus cisplatin as induction chemotherapy for Stage III non-small cell lung cancer.
Migliorino MR; De Marinis F; Nelli F; Facciolo F; Ammaturo MV; Cipri A; Belli R; Ariganello O; Diana F; Di Molfetta M; Martelli O
Lung Cancer; 2002 Mar; 35(3):319-27. PubMed ID: 11844608
[TBL] [Abstract][Full Text] [Related]
15. A randomized phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer.
Uramoto H; Nakanishi R; Nagashima A; Uchiyama A; Inoue M; Osaki T; Yoshimatsu T; Sakata H; Nakanishi K; Yasumoto K
Anticancer Res; 2010 Nov; 30(11):4695-9. PubMed ID: 21115926
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955).
Van Zandwijk N; Smit EF; Kramer GW; Schramel F; Gans S; Festen J; Termeer A; Schlosser NJ; Debruyne C; Curran D; Giaccone G
J Clin Oncol; 2000 Jul; 18(14):2658-64. PubMed ID: 10894864
[TBL] [Abstract][Full Text] [Related]
17. [Treatment outcome of locally advanced stage IIIA/B lung cancer].
Cicenas S; Zaliene A; Atkocius V
Medicina (Kaunas); 2009; 45(6):452-9. PubMed ID: 19605965
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of induction gemcitabine and carboplatin followed by conformal thoracic radiation to 74 Gy with weekly paclitaxel and carboplatin in unresectable stage III non-small cell lung cancer.
Bepler G; Dilling TJ; Wagner H; Hazelton T; Williams C; Chen DT; Greenberg H; Walsh F; Simon G; Tanvetyanon T; Chiappori A; Haura E; Stevens C
J Thorac Oncol; 2011 Mar; 6(3):553-8. PubMed ID: 21289520
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of carboplatin and gemcitabine as adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: a report from the Central Japan Lung Study Group, CJLSG 0503 trial.
Usami N; Yokoi K; Hasegawa Y; Taniguchi H; Shindo J; Yamamoto M; Suzuki R; Imaizumi K; Kondo M; Shimokata K;
Int J Clin Oncol; 2010 Dec; 15(6):583-7. PubMed ID: 20714770
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy in locally advanced non-small cell lung cancer.
Hamouda W; Dorgham Y; Yosry A; Abdel Wahab M
Gulf J Oncolog; 2007 Jul; (2):55-64. PubMed ID: 20084725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]